How has been the historical performance of Fermenta Biotec.?
Fermenta Biotec has shown significant recovery in its financial performance, with net sales rising to 469.48 Cr in Mar'25 from 335.66 Cr in Mar'24, and profit after tax rebounding to 76.40 Cr from a loss of 24.01 Cr in Mar'24. Overall, the company has improved profitability and reduced liabilities, indicating a positive trend.
Answer:The historical performance of Fermenta Biotec shows significant fluctuations over the years, with a notable recovery in recent periods.Breakdown:
Fermenta Biotec's net sales increased from 335.66 Cr in Mar'24 to 469.48 Cr in Mar'25, following a dip in Mar'23 at 349.94 Cr and a peak of 398.52 Cr in Mar'22. Total operating income mirrored this trend, rising to 469.48 Cr in Mar'25 from 335.66 Cr in Mar'24. The company's operating profit (PBDIT) also saw a substantial rise, reaching 121.62 Cr in Mar'25 compared to 39.32 Cr in Mar'24, after experiencing lower figures in the preceding years. Profit before tax turned positive at 83.21 Cr in Mar'25, recovering from a loss of 9.87 Cr in Mar'24 and a significant loss of 51.87 Cr in Mar'23. Consequently, profit after tax rebounded to 76.40 Cr in Mar'25 from a loss of 24.01 Cr in Mar'24. The company's total liabilities decreased to 585.83 Cr in Mar'25 from 525.83 Cr in Mar'24, while total assets also rose to 585.83 Cr in Mar'25. Cash flow from operating activities was 40.00 Cr in Mar'25, down from 105.00 Cr in Mar'24, contributing to a net cash outflow of 10.00 Cr in Mar'25. Overall, the financial metrics indicate a recovery trajectory for Fermenta Biotec, particularly in profitability and sales.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
